458 related articles for article (PubMed ID: 20846597)
1. Iron overload cardiomyopathy: better understanding of an increasing disorder.
Gujja P; Rosing DR; Tripodi DJ; Shizukuda Y
J Am Coll Cardiol; 2010 Sep; 56(13):1001-12. PubMed ID: 20846597
[TBL] [Abstract][Full Text] [Related]
2. Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment.
Murphy CJ; Oudit GY
J Card Fail; 2010 Nov; 16(11):888-900. PubMed ID: 21055653
[TBL] [Abstract][Full Text] [Related]
3. Iron overload cardiomyopathy: from diagnosis to management.
Díez-López C; Comín-Colet J; González-Costello J
Curr Opin Cardiol; 2018 May; 33(3):334-340. PubMed ID: 29543671
[TBL] [Abstract][Full Text] [Related]
4. An autopsy case of secondary iron-overload cardiomyopathy.
Kobayashi T; Tadokoro H; Matsumoto K
Intern Med; 2013; 52(12):1369-73. PubMed ID: 23774549
[TBL] [Abstract][Full Text] [Related]
5. Advancement of echocardiography for surveillance of iron overload cardiomyopathy: comparison to cardiac magnetic resonance imaging.
Zimmerman MJ; Rosing DR; Shizukuda Y
J Echocardiogr; 2021 Sep; 19(3):141-149. PubMed ID: 33772457
[TBL] [Abstract][Full Text] [Related]
6. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
[TBL] [Abstract][Full Text] [Related]
7. Prooxidant mechanisms in iron overload cardiomyopathy.
Cheng CF; Lian WS
Biomed Res Int; 2013; 2013():740573. PubMed ID: 24350287
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of myocardial iron overload using cardiovascular magnetic resonance imaging.
Mavrogeni S; Pepe A; Lombardi M
Hellenic J Cardiol; 2011; 52(5):385-90. PubMed ID: 21940285
[No Abstract] [Full Text] [Related]
9. Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.
Di Odoardo LAF; Giuditta M; Cassinerio E; Roghi A; Pedrotti P; Vicenzi M; Sciumbata VM; Cappellini MD; Pierini A
Intern Emerg Med; 2017 Sep; 12(6):799-809. PubMed ID: 28456904
[TBL] [Abstract][Full Text] [Related]
10. An autopsy case of secondary iron-overload cardiomyopathy.
Ishizaka N; Yuki M; Kanzaki Y
Intern Med; 2014; 53(4):351. PubMed ID: 24531101
[No Abstract] [Full Text] [Related]
11. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the diagnosis and the treatment of iron overload diseases.
Brissot P
Expert Rev Gastroenterol Hepatol; 2016; 10(3):359-70. PubMed ID: 26561304
[TBL] [Abstract][Full Text] [Related]
13. Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Rhee JW; Yi H; Thomas D; Lam CK; Belbachir N; Tian L; Qin X; Malisa J; Lau E; Paik DT; Kim Y; Choi BS; Sayed N; Sallam K; Liao R; Wu JC
Cell Rep; 2020 Jul; 32(2):107886. PubMed ID: 32668256
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.
Sadaf A; Hasan B; Das JK; Colan S; Alvi N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011626. PubMed ID: 29998494
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.
Gordan R; Wongjaikam S; Gwathmey JK; Chattipakorn N; Chattipakorn SC; Xie LH
Heart Fail Rev; 2018 Sep; 23(5):801-816. PubMed ID: 29675595
[TBL] [Abstract][Full Text] [Related]
16. Sudden Onset Iron Overload Cardiomyopathy After Liver Transplantation.
Habib A; Shaaban A; Thompson J; Chinnakotla S; Martin CM; Vercellotti GM
J Investig Med High Impact Case Rep; 2023; 11():23247096231159812. PubMed ID: 36914978
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.
Anderson LJ; Holden S; Davis B; Prescott E; Charrier CC; Bunce NH; Firmin DN; Wonke B; Porter J; Walker JM; Pennell DJ
Eur Heart J; 2001 Dec; 22(23):2171-9. PubMed ID: 11913479
[TBL] [Abstract][Full Text] [Related]
18. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
Kolnagou A; Michaelides Y; Kontos C; Kyriacou K; Kontoghiorghes GJ
Hemoglobin; 2008; 32(1-2):17-28. PubMed ID: 18274979
[TBL] [Abstract][Full Text] [Related]
19. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.
Das SK; Zhabyeyev P; Basu R; Patel VB; Dyck JRB; Kassiri Z; Oudit GY
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208771
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing myocardial iron overload.
Hoffbrand AV
Eur Heart J; 2001 Dec; 22(23):2140-1. PubMed ID: 11913473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
